176 companies
Axsome Therapeutics
Market Cap: US$5.1b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$107.22
7D
-1.5%
1Y
38.6%
AVITA Medical
Market Cap: US$176.8m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$6.37
7D
-31.7%
1Y
-19.6%
Ascendis Pharma
Market Cap: US$9.5b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$157.54
7D
-1.2%
1Y
28.3%
ZEEKR Intelligent Technology Holding
Market Cap: US$7.3b
An investment holding company, engages in the research and development, production, commercialization, and sale of the electric vehicles and batteries.
ZK
US$28.92
7D
11.0%
1Y
8.7%
Travere Therapeutics
Market Cap: US$1.9b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$21.15
7D
3.5%
1Y
216.1%
FTC Solar
Market Cap: US$53.6m
Engages in the manufacture and service of solar tracker systems in the United States, Asia, Europe, the Middle East, North Africa, South Africa, and Australia.
FTCI
US$4.15
7D
25.8%
1Y
-14.5%
Ardelyx
Market Cap: US$784.8m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.38
7D
-7.1%
1Y
-56.6%
Super Micro Computer
Market Cap: US$26.9b
Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.
SMCI
US$43.96
7D
36.9%
1Y
-51.4%
Evolus
Market Cap: US$644.1m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$10.00
7D
-0.9%
1Y
-27.0%
Legend Biotech
Market Cap: US$5.1b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$27.69
7D
-12.9%
1Y
-38.7%
UroGen Pharma
Market Cap: US$455.1m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$9.85
7D
-7.7%
1Y
-25.4%
Soleno Therapeutics
Market Cap: US$3.7b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$75.07
7D
-1.6%
1Y
64.4%
Hess
Market Cap: US$41.5b
An exploration and production company, explores, develops, produces, purchases, transports, and sells crude oil, natural gas liquids, and natural gas in the United States, Guyana, the Malaysia/Thailand Joint Development Area, and Malaysia.
HES
US$135.07
7D
3.2%
1Y
-13.6%
Hess Midstream
Market Cap: US$8.4b
Owns, operates, develops, and acquires midstream assets and provide fee-based services to Hess and third-party customers in the United States.
HESM
US$38.86
7D
4.8%
1Y
10.7%
Infinity Natural Resources
Market Cap: US$1.1b
Engages in the acquisition, exploration, and development of properties to produce oil, natural gas, and natural gas liquids from underground reservoirs in the United States.
INR
US$17.98
7D
5.6%
1Y
n/a
Similarweb
Market Cap: US$640.7m
Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.
SMWB
US$7.36
7D
-1.1%
1Y
-5.8%
Pagaya Technologies
Market Cap: US$1.1b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services and other service providers, their customers, and asset investors in the United States, Israel, and the Cayman Islands.
PGY
US$14.04
7D
1.2%
1Y
19.1%
ACADIA Pharmaceuticals
Market Cap: US$2.9b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$17.60
7D
4.0%
1Y
18.5%
Nutanix
Market Cap: US$21.8b
Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.
NTNX
US$80.66
7D
8.4%
1Y
16.9%
Arcutis Biotherapeutics
Market Cap: US$1.6b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$13.63
7D
0.9%
1Y
49.5%
Elastic
Market Cap: US$9.7b
A search artificial intelligence (AI) company, delivers hosted and managed solutions designed to run in hybrid, public or private clouds, and multi-cloud environments in the United States and internationally.
ESTC
US$92.19
7D
6.9%
1Y
-14.8%
Daqo New Energy
Market Cap: US$1.0b
Manufactures and sells polysilicon to photovoltaic product manufacturers in the People’s Republic of China.
DQ
US$14.84
7D
11.9%
1Y
-21.6%
Sachem Capital
Market Cap: US$45.9m
Operates as a real estate finance company in the United States.
SACH
US$0.94
7D
-1.8%
1Y
-70.7%
CareTrust REIT
Market Cap: US$5.4b
CareTrust REIT is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of seniors housing and healthcare-related properties.
CTRE
US$28.64
7D
-1.1%
1Y
15.2%
Atour Lifestyle Holdings
Market Cap: US$4.0b
Through its subsidiaries, develops lifestyle brands around hotel offerings in the People’s Republic of China.
ATAT
US$29.83
7D
5.0%
1Y
61.0%
Atlanticus Holdings
Market Cap: US$866.9m
A financial technology company, provides products and services to lenders in the United States.
ATLC
US$52.80
7D
-5.3%
1Y
120.6%
TWFG
Market Cap: US$1.8b
Operates an independent distribution platform for personal and commercial insurance products in the United States.
TWFG
US$33.99
7D
6.1%
1Y
n/a
BioCryst Pharmaceuticals
Market Cap: US$2.1b
A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.
BCRX
US$10.21
7D
2.4%
1Y
62.6%
Victory Capital Holdings
Market Cap: US$4.3b
Operates as an asset management company in the United States and internationally.
VCTR
US$63.81
7D
6.2%
1Y
22.6%
Midland States Bancorp
Market Cap: US$393.5m
Operates as a financial holding company for Midland States Bank that provides various banking products and services to individuals, businesses, municipalities, and other entities.
MSBI
US$18.50
7D
1.3%
1Y
-21.1%
TriSalus Life Sciences
Market Cap: US$158.1m
Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics for improving outcomes for patients with difficult-to-treat liver and pancreatic cancers.
TLSI
US$5.11
7D
-1.5%
1Y
-47.3%
Vericel
Market Cap: US$2.1b
A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.
VCEL
US$41.49
7D
-0.9%
1Y
-12.9%
Dime Community Bancshares
Market Cap: US$1.2b
Operates as the holding company for Dime Community Bank that engages in the provision of various commercial banking and financial services.
DCOM
US$27.30
7D
2.7%
1Y
37.9%
Constellium
Market Cap: US$1.8b
Engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industrial, and defense end-markets.
CSTM
US$12.08
7D
8.0%
1Y
-42.0%
Krystal Biotech
Market Cap: US$3.8b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$130.33
7D
-5.0%
1Y
-20.4%
BeiGene
Market Cap: US$23.8b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$225.77
7D
-4.3%
1Y
32.0%